PROCTER & GAMBLE HEALTH
Back to Cashflow Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Jun2024 | Mar2024 | Jun2023 | Jun2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-235 Cr | ₹-418 Cr | ₹-418 Cr | ₹-98 Cr | ₹-289 Cr |
What is the latest Cash Flow from Financing Activities ratio of PROCTER & GAMBLE HEALTH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-235 Cr |
| Jun2024 | ₹-418 Cr |
| Mar2024 | ₹-418 Cr |
| Jun2023 | ₹-98 Cr |
| Jun2022 | ₹-289 Cr |
How is Cash Flow from Financing Activities of PROCTER & GAMBLE HEALTH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-235 Cr | Negative | |
| Jun2024 | ₹-418 Cr | Negative | |
| Mar2024 | ₹-418 Cr | Negative | |
| Jun2023 | ₹-98 Cr | Negative | |
| Jun2022 | ₹-289 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PROCTER & GAMBLE HEALTH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PROCTER & GAMBLE HEALTH | ₹8,736.5 Cr | -1.5% | -7.6% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PROCTER & GAMBLE HEALTH | -1.5% |
-7.6% |
-0.6% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses